Alterations in phage-typing patterns in vancomycin-intermediate Staphylococcus aureus

被引:4
|
作者
Gustafson, JE [1 ]
O'Brien, FG
Coombs, GW
Malkowski, MJ
Grubb, WB
Pfeltz, RF
Wilkinson, BJ
机构
[1] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA
[2] Curtin Univ Technol, Gram Posit Bacteria Typing & Res Unit, Perth, WA 6845, Australia
[3] Royal Perth Hosp, Perth, WA 6845, Australia
[4] Illinois State Univ, Dept Biol Sci, Microbiol Grp, Normal, IL 61790 USA
关键词
D O I
10.1099/jmm.0.05210-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The ability of phage-typing and Smal chromosomal RFLPs to conclude appropriate strain relatedness between a collection of 12 well-characterized in vitro-selected vancomycin-intermediate Staphylococcus aureus (VISA) strains and their seven vancomycin-susceptible parent strains is reported. Generally, no Smal RFLP alterations were observed in VISA strains when they were compared with their respective parent strains, and clonal relationships between isogenic strains were clearly evident. Unlike the Smal RFLP results, parent strains and VISA derivatives generally did not share similar phage-typing profiles. Depending on the phage set investigated, some VISA strains even became untypable by this method. Loss of phage infectivity is probably due to cell wall (phage receptor) alterations that are expressed by the VISA strains investigated. Collectively, these findings indicate that inappropriate relationships between VISA and vancomycin-susceptible parents might be drawn if only phage-typing and antibiotic susceptibility are utilized to determine epidemiological relationships.
引用
收藏
页码:711 / 714
页数:4
相关论文
共 50 条
  • [31] PHAGE-TYPING OF STAPHYLOCOCCUS-EPIDERMIDIS
    VANBOVEN, CPA
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1976, : 149 - 152
  • [32] Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus among Methicillin-Resistant Staphylococcus aureus
    Chaudhary, Bajarangi Lal
    Bisht, Dakshina
    Faujdar, Sameer
    ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2022, 14 (01) : 16 - 20
  • [33] First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
    Ploy, MC
    Grélaud, C
    Martin, C
    de Lumley, L
    Denis, F
    LANCET, 1998, 351 (9110): : 1212 - 1212
  • [34] Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units
    Hu, Han-Chung
    Kao, Kuo-Chin
    Chiu, Li-Chung
    Chang, Chih-Hao
    Hung, Chen-Yiu
    Li, Li-Fu
    Liu, Tsui-Ping
    Lin, Lee-Chung
    Chen, Ning-Hung
    Huang, Chung-Chi
    Yang, Cheng-Ta
    Lu, Jang-Jih
    BMC INFECTIOUS DISEASES, 2015, 15
  • [35] Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus
    Cui, Longzhu
    Neoh, Hui-min
    Shoji, Mitsutaka
    Hiramatsu, Keiichi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) : 1231 - 1234
  • [36] Genome Sequence-Based Discriminator for Vancomycin-Intermediate Staphylococcus aureus
    Rishishwar, Lavanya
    Petit, Robert A., III
    Kraft, Colleen S.
    Jordan, I. King
    JOURNAL OF BACTERIOLOGY, 2014, 196 (05) : 940 - 948
  • [37] Vancomycin-intermediate Staphylococcus aureus in a home health-care patient
    Hageman, JC
    Pegues, DA
    Jepson, C
    Bell, RL
    Guinan, M
    Ward, KW
    Cohen, MD
    Hindler, JA
    Tenover, FC
    McAllister, SK
    Kellum, ME
    Fridkin, SK
    EMERGING INFECTIOUS DISEASES, 2001, 7 (06) : 1023 - 1025
  • [38] Comparative proteomic analysis of vancomycin-sensitive and vancomycin-intermediate resistant Staphylococcus aureus
    Hu, Jian
    Han, Xinjun
    Ma, Xiaoxue
    Chen, Xutao
    Zhou, Zhenping
    Peng, Peilan
    Yu, Zhao
    Hou, Yongzhi
    Han, Peiru
    Pang, Long
    Yang, Yali
    Xu, Jia
    Wu, Wenhui
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (01) : 203 - 208
  • [39] Risk factors for vancomycin treatment failure in heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia
    Yun, Ji Hyun
    Chang, Euijin
    Bae, Seongman
    Jung, Jiwon
    Kim, Min Jae
    Chong, Yong Pil
    Kim, Sung-Han
    Choi, Sang-Ho
    Lee, Sang-Oh
    Kim, Yang Soo
    MICROBIOLOGY SPECTRUM, 2024, 12 (08):
  • [40] Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units
    Han-Chung Hu
    Kuo-Chin Kao
    Li-Chung Chiu
    Chih-Hao Chang
    Chen-Yiu Hung
    Li-Fu Li
    Tsui-Ping Liu
    Lee-Chung Lin
    Ning-Hung Chen
    Chung-Chi Huang
    Cheng-Ta Yang
    Jang-Jih Lu
    BMC Infectious Diseases, 15